Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Neuroblastoma 1Lymphoma 1Leukemia 1Immunologic Deficiency Syndromes 1Anemia 1

Interventions

Cyclophosphamide 37fludarabine phosphate 31Busulfan 25Antilymphocyte Serum 22Mycophenolic Acid 20Melphalan 19Cyclosporine 19Peripheral Blood Stem Cell Transplantation 16Filgrastim 16Cord Blood Stem Cell Transplantation 16Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 14Methylprednisolone 13fludarabine 11Methotrexate 8Epoetin Alfa 8Etoposide 7Cytarabine 7Thiotepa 6Alemtuzumab 6thymoglobulin 4Granulocyte Colony-Stimulating Factor 4Darbepoetin alfa 3Bone Marrow Transplantation 3Stem Cell Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × fosphenytoin × Classical hematology × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡